PHARMACEUTICAL COMPANIES & MEDICAL DEVICE INDUSTRY
For the promotion of their products, it is the sponsor’s responsibility to comply with:
• AIFA Italian Medicines Agency (www.agenziafarmaco.gov.it)
• EFPIA code of practice (https://www.efpia.eu/relationships-code/the-efpia-code/)
• MedTech Europe (https://www.medtecheurope.org)
EthicalMedTech & e4ethics Compliance
The 34th European Meeting on Hypertension and Cardiovascular Protection is found COMPLIANT with the MedTech Europe Code of Ethical Business Practice and EFPIA Code of Practice.
This information is available on www.ethicalmedtech.eu with the reference: EMT-24-01130
EthicalMedTech is a platform, supported by MedTech Europe, dedicated to ethics and compliance projects in the MedTech industry. e4ethics is a platform designed by the European Federation of Pharmaceuticals Industries and Associations (EFPIA), dedicated to the provisions of the EFPIA Code of Practice.
Since 1st January 2021, the two trade associations, MedTech Europe and EFPIA, have a unique and common platform assessing Third-Party Organised Educational Events (TPOEs) – Conference Vetting System (CVS).
WHAT IS THE MEDTECH EUROPE CODE?
Important updates about the Code of Ethics
A code for more transparency, effective 1st January 2018
The MedTech Europe Code of Ethical Business Practice regulates all aspects of the industry’s relationships with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs).
One important change introduced by the Code as of 1 January 2018 is discontinuation of direct sponsorship of HCPs. As of that date, independent medical education has to be supported exclusively by means of Educational Grants. Such Educational Grants can be provided to HCOs and PCOs.
AIM GROUP INTERNATIONAL is officially recognised by MedTech Europe as a compliant, trusted PCO to rely on in the process of organising medical educational events.
OFFICIAL ITALIAN AGENCY FOR AIFA PROCEDURE
Any pharmaceutical company supporting or participating in a congress in Italy, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The request of authorization must be submitted within 60 days before the starting date of the event.
Italian pharmaceutical companies are advised to contact the Official Italian Agency appointed by the Organising:
The appointed agency for AIFA submission is:
AIM Group International – AIM Education S.r.l.
Cristina Ghidoli
Viale Enrico Forlani, 23
20134 Milan, Italy
Tel. +39 02 56601.1
e-mail: aifa@aimgroup.eu/c.ghidoli@aimgroup.eu
